VANCOUVER, Nov. 16, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that Chris Clark, Chief Financial Officer of Neovasc will present an overview of the Company at two investor conferences this week in New York.
Stifel 2015 Healthcare Conference
The New York Palace Hotel, New York
Wednesday, November 18, 2015 at 4:30 pm ET
Canaccord Genuity 2015 Medical Technology & Diagnostic Forum
Westin Grand Central, New York
Thursday, November 19, 2015 at 2:00 pm ET
A link to the live audio webcast of each presentation will be available on the Presentations and Events page of the Investors section of Neovasc's website at www.neovasc.com. Please connect at least 15 minutes prior to the event to ensure adequate time for any software download that may be required to hear the webcast.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products in development include the Tiara™, for the transcatheter treatment of mitral valve disease and the Neovasc Reducer™ for the treatment of refractory angina. For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.
For further information: Investor Relations: Neovasc Inc., Chris Clark, 604 248-4138, firstname.lastname@example.org